{"id":1003,"date":"2020-02-01T13:32:09","date_gmt":"2020-02-01T12:32:09","guid":{"rendered":"https:\/\/www.parvilla-invest.fr\/fonds-venture\/"},"modified":"2026-03-17T21:42:52","modified_gmt":"2026-03-17T20:42:52","slug":"venture-funds-life-sciences","status":"publish","type":"page","link":"https:\/\/www.parvilla-invest.fr\/en\/venture-funds-life-sciences\/","title":{"rendered":"Venture Funds \/ Life Sciences"},"content":{"rendered":"<div class=\"wpb-content-wrapper\"><p>[vc_row class=&#8221;tablecustomcss&#8221;][vc_column][vc_column_text css=&#8221;&#8221;]<\/p>\n<table style=\"height: 179px;\" width=\"1200\">\n<tbody>\n<tr class=\"border-top\">\n<td class=\"align-center\" style=\"width: 220px;\" rowspan=\"4\"><img decoding=\"async\" src=\"https:\/\/www.parvilla-invest.fr\/wp-content\/uploads\/2020\/02\/logo7.jpg\" \/><\/p>\n<p style=\"text-align: center;\">Sofinnova is one of the<br \/>\nfore-front GPs<br \/>\nin the Life Sciences space<\/p>\n<\/td>\n<td class=\"border-right\"><span style=\"color: #254f9d;\"><strong>Fund SOFINNOVA VIII<\/strong><\/span><\/td>\n<td class=\"border-right\"><span style=\"color: #254f9d;\"><strong>Fund SOFINNOVA<br \/>\nCROSS OVER<br \/>\n<\/strong><\/span><\/td>\n<td class=\"border-right\"><span style=\"color: #254f9d;\"><strong>Fund SOFINNOVA IX<\/strong><\/span><\/td>\n<td class=\"border-right\"><span style=\"color: #254f9d;\"><strong>Fund SOFINNOVA MD START<br \/>\n<\/strong><\/span><\/td>\n<td><span style=\"color: #254f9d;\"><strong>Fund SOFINNOVA X<br \/>\n<\/strong><\/span><\/td>\n<td><span style=\"color: #254f9d;\"><strong>Fund SOFINNOVA XI<br \/>\n<\/strong><\/span><\/td>\n<\/tr>\n<tr>\n<td class=\"border-right\"><strong>Vintage year: <\/strong>2016<\/td>\n<td class=\"border-right\"><strong>Vintage year: <\/strong>2017<\/td>\n<td class=\"border-right\"><strong>Vintage year: <\/strong>2018<\/td>\n<td class=\"border-right\"><strong>Vintage year:<\/strong>2019<\/td>\n<td><strong>Vintage year: <\/strong>2021<\/td>\n<td><strong>Vintage year: <\/strong>2024<\/td>\n<\/tr>\n<tr>\n<td class=\"border-right\">Pharma fund<\/td>\n<td class=\"border-right\">Cross over fund<\/td>\n<td class=\"border-right\">Pharma fund<\/td>\n<td class=\"border-right\">Early stage MedTech<\/td>\n<td>Pharma fund<\/td>\n<td>Pharma fund<\/td>\n<\/tr>\n<tr>\n<td class=\"border-right\">Fully Invested<\/td>\n<td class=\"border-right\">Fully Invested<\/td>\n<td class=\"border-right\">Fully Invested<\/td>\n<td class=\"border-right\">Fully Invested<\/td>\n<td>Fully Invested<\/td>\n<td>Investing<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<table>\n<tbody>\n<tr class=\"border-top\">\n<td class=\"align-center\" style=\"width: 220px;\"><img decoding=\"async\" src=\"https:\/\/www.parvilla-invest.fr\/wp-content\/uploads\/2020\/02\/logo6.jpg\" \/><\/p>\n<p style=\"text-align: center;\"><span style=\"color: #254f9d;\"><strong>Alven Fund<\/strong><\/span><\/p>\n<\/td>\n<td><span style=\"color: #254f9d;\"><strong>Activity :\u00a0<\/strong><\/span>European digital and<br \/>\ntechnology<\/td>\n<td><span style=\"color: #254f9d;\"><strong>Vintage year:<\/strong><\/span><br \/>\n2016<\/td>\n<td><span style=\"color: #254f9d;\"><strong>Fully Invested<\/strong><\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<table>\n<tbody>\n<tr class=\"border-top\">\n<td class=\"align-center\" style=\"width: 220px;\" rowspan=\"4\"><img decoding=\"async\" src=\"https:\/\/www.parvilla-invest.fr\/wp-content\/uploads\/2020\/02\/logo9.jpg\" \/><\/p>\n<p style=\"text-align: center;\"><span style=\"color: #254f9d;\"><strong>Deep Tech &amp; digital in<br \/>\nEurope<\/strong><\/span><\/p>\n<\/td>\n<td class=\"border-right\"><span style=\"color: #254f9d;\"><strong>Fonds Elaia Delta<\/strong><\/span><\/td>\n<td><span style=\"color: #254f9d;\"><strong>Fonds Elaia Alpha 2<\/strong><\/span><\/td>\n<\/tr>\n<tr>\n<td class=\"border-right\"><span style=\"color: #254f9d;\"><strong>Vintage year: <\/strong><\/span>2016<\/td>\n<td><span style=\"color: #254f9d;\"><strong>Vintage year: <\/strong><\/span>2021<\/td>\n<\/tr>\n<tr>\n<td class=\"border-right\"><span style=\"color: #254f9d;\"><strong>Fully Invested<\/strong><\/span><\/td>\n<td><span style=\"color: #254f9d;\"><strong>Fully Invested<\/strong><\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<table>\n<tbody>\n<tr class=\"border-top\">\n<td class=\"align-center\" style=\"width: 220px;\" rowspan=\"4\"><img decoding=\"async\" src=\"https:\/\/www.parvilla-invest.fr\/wp-content\/uploads\/2020\/02\/logo8.jpg\" \/><\/p>\n<p style=\"text-align: center;\">LSP is one of the most established GPs in Life Sciences<\/p>\n<\/td>\n<td class=\"border-right\"><span style=\"color: #254f9d;\"><strong>Fund LSP HEF 2<\/strong><\/span><\/td>\n<td class=\"border-right\"><span style=\"color: #254f9d;\"><strong>Fund LSP 6<\/strong><\/span><\/td>\n<td><span style=\"color: #254f9d;\"><strong>Fund LSP 7<\/strong><\/span><\/td>\n<\/tr>\n<tr>\n<td class=\"border-right\"><strong>Vintage year: <\/strong>2017<\/td>\n<td class=\"border-right\"><strong>Vintage year: <\/strong>2018<\/td>\n<td><strong>Vintage year: <\/strong>2021<\/td>\n<\/tr>\n<tr>\n<td class=\"border-right\">Medtech only<\/td>\n<td class=\"border-right\">Pharma fund<\/td>\n<td>Pharma fund<\/td>\n<\/tr>\n<tr class=\"border-bottom\">\n<td class=\"border-right\"><span style=\"color: #254f9d;\"><strong>Fully Invested<\/strong><\/span><\/td>\n<td class=\"border-right\"><span style=\"color: #254f9d;\"><strong>Fully Invested<\/strong><\/span><\/td>\n<td><span style=\"color: #254f9d;\"><strong>Fully Invested<\/strong><\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<table>\n<tbody>\n<tr class=\"border-bottom\">\n<td style=\"width: 220px;\"><img decoding=\"async\" src=\"https:\/\/www.parvilla-invest.fr\/wp-content\/uploads\/2020\/02\/logo5.jpg\" \/><\/p>\n<p style=\"text-align: center;\"><span style=\"color: #254f9d;\"><strong>Health for Life Capital<br \/>\nFund II<br \/>\n<\/strong><\/span><\/p>\n<\/td>\n<td style=\"width: 285px;\"><span style=\"color: #254f9d;\"><strong>Activity : <\/strong><\/span>Pharma fund with a<br \/>\nfocus on microbiom. Invests in<br \/>\nEurope but also in the USA.<\/td>\n<td style=\"width: 205px;\"><span style=\"color: #254f9d;\"><strong>Vintage year: <\/strong><\/span>2019<\/td>\n<td><span style=\"color: #254f9d;\"><strong>Fully Invested<\/strong><\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<table>\n<tbody>\n<tr class=\"border-bottom\">\n<td style=\"width: 220px;\"><img decoding=\"async\" src=\"https:\/\/www.parvilla-invest.fr\/wp-content\/uploads\/2020\/03\/IQ-logo-on-white.png\" \/><\/p>\n<p style=\"text-align: center;\"><span style=\"color: #254f9d;\"><strong>IQ Growth<\/strong><\/span><\/p>\n<\/td>\n<td style=\"width: 285px;\"><span style=\"color: #254f9d;\"><strong>Activity\u00a0 : <\/strong><\/span>IQ Capital is a well established VC based in Cambridge<\/p>\n<p>Fund dedicated to cross-over.<\/td>\n<td style=\"width: 205px;\"><span style=\"color: #254f9d;\"><strong>Vintage year: <\/strong><\/span>2020<\/td>\n<td><span style=\"color: #254f9d;\"><strong>Fully Invested<\/strong><\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>[\/vc_column_text][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>[vc_row class=&#8221;tablecustomcss&#8221;][vc_column][vc_column_text css=&#8221;&#8221;] Sofinnova is one of the fore-front GPs in the Life Sciences space Fund SOFINNOVA VIII Fund SOFINNOVA CROSS OVER Fund SOFINNOVA IX Fund SOFINNOVA MD START Fund SOFINNOVA X Fund SOFINNOVA XI Vintage year: 2016 Vintage year: 2017 Vintage year: 2018 Vintage year:2019 Vintage year: 2021 Vintage year: 2024 Pharma fund Cross [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":1111,"parent":0,"menu_order":400,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-1003","page","type-page","status-publish","has-post-thumbnail","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Venture Funds \/ Life Sciences - Parvilla Investissements<\/title>\n<meta name=\"description\" content=\"Parvilla Investissements is investing 30% in Venture \/ Life Sciences funds\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.parvilla-invest.fr\/en\/venture-funds-life-sciences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Venture Funds \/ Life Sciences - Parvilla Investissements\" \/>\n<meta property=\"og:description\" content=\"Parvilla Investissements is investing 30% in Venture \/ Life Sciences funds\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.parvilla-invest.fr\/en\/venture-funds-life-sciences\/\" \/>\n<meta property=\"og:site_name\" content=\"Parvilla Investissements\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-17T20:42:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.parvilla-invest.fr\/wp-content\/uploads\/2020\/02\/AdobeStock_201606422-1024x576.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"576\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.parvilla-invest.fr\/en\/venture-funds-life-sciences\/\",\"url\":\"https:\/\/www.parvilla-invest.fr\/en\/venture-funds-life-sciences\/\",\"name\":\"Venture Funds \/ Life Sciences - Parvilla Investissements\",\"isPartOf\":{\"@id\":\"https:\/\/www.parvilla-invest.fr\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.parvilla-invest.fr\/en\/venture-funds-life-sciences\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.parvilla-invest.fr\/en\/venture-funds-life-sciences\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.parvilla-invest.fr\/wp-content\/uploads\/2020\/02\/AdobeStock_201606422.jpeg\",\"datePublished\":\"2020-02-01T12:32:09+00:00\",\"dateModified\":\"2026-03-17T20:42:52+00:00\",\"description\":\"Parvilla Investissements is investing 30% in Venture \/ Life Sciences funds\",\"breadcrumb\":{\"@id\":\"https:\/\/www.parvilla-invest.fr\/en\/venture-funds-life-sciences\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.parvilla-invest.fr\/en\/venture-funds-life-sciences\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.parvilla-invest.fr\/en\/venture-funds-life-sciences\/#primaryimage\",\"url\":\"https:\/\/www.parvilla-invest.fr\/wp-content\/uploads\/2020\/02\/AdobeStock_201606422.jpeg\",\"contentUrl\":\"https:\/\/www.parvilla-invest.fr\/wp-content\/uploads\/2020\/02\/AdobeStock_201606422.jpeg\",\"width\":2560,\"height\":1440,\"caption\":\"Female and Male Scientists Working on their Computers In Big Modern Laboratory. Various Shelves with Beakers, Chemicals and Different Technical Equipment is Visible.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.parvilla-invest.fr\/en\/venture-funds-life-sciences\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.parvilla-invest.fr\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Venture Funds \/ Life Sciences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.parvilla-invest.fr\/fr\/#website\",\"url\":\"https:\/\/www.parvilla-invest.fr\/fr\/\",\"name\":\"Parvilla Investissements\",\"description\":\"Soci\u00e9t\u00e9 d&#039;investissement d\u00e9di\u00e9e au Private Equity\",\"publisher\":{\"@id\":\"https:\/\/www.parvilla-invest.fr\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.parvilla-invest.fr\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.parvilla-invest.fr\/fr\/#organization\",\"name\":\"Parvilla Invest\",\"url\":\"https:\/\/www.parvilla-invest.fr\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.parvilla-invest.fr\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.parvilla-invest.fr\/wp-content\/uploads\/2020\/01\/logo-1.jpg\",\"contentUrl\":\"https:\/\/www.parvilla-invest.fr\/wp-content\/uploads\/2020\/01\/logo-1.jpg\",\"width\":235,\"height\":59,\"caption\":\"Parvilla Invest\"},\"image\":{\"@id\":\"https:\/\/www.parvilla-invest.fr\/fr\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Venture Funds \/ Life Sciences - Parvilla Investissements","description":"Parvilla Investissements is investing 30% in Venture \/ Life Sciences funds","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.parvilla-invest.fr\/en\/venture-funds-life-sciences\/","og_locale":"en_US","og_type":"article","og_title":"Venture Funds \/ Life Sciences - Parvilla Investissements","og_description":"Parvilla Investissements is investing 30% in Venture \/ Life Sciences funds","og_url":"https:\/\/www.parvilla-invest.fr\/en\/venture-funds-life-sciences\/","og_site_name":"Parvilla Investissements","article_modified_time":"2026-03-17T20:42:52+00:00","og_image":[{"width":1024,"height":576,"url":"https:\/\/www.parvilla-invest.fr\/wp-content\/uploads\/2020\/02\/AdobeStock_201606422-1024x576.jpeg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.parvilla-invest.fr\/en\/venture-funds-life-sciences\/","url":"https:\/\/www.parvilla-invest.fr\/en\/venture-funds-life-sciences\/","name":"Venture Funds \/ Life Sciences - Parvilla Investissements","isPartOf":{"@id":"https:\/\/www.parvilla-invest.fr\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.parvilla-invest.fr\/en\/venture-funds-life-sciences\/#primaryimage"},"image":{"@id":"https:\/\/www.parvilla-invest.fr\/en\/venture-funds-life-sciences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.parvilla-invest.fr\/wp-content\/uploads\/2020\/02\/AdobeStock_201606422.jpeg","datePublished":"2020-02-01T12:32:09+00:00","dateModified":"2026-03-17T20:42:52+00:00","description":"Parvilla Investissements is investing 30% in Venture \/ Life Sciences funds","breadcrumb":{"@id":"https:\/\/www.parvilla-invest.fr\/en\/venture-funds-life-sciences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.parvilla-invest.fr\/en\/venture-funds-life-sciences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.parvilla-invest.fr\/en\/venture-funds-life-sciences\/#primaryimage","url":"https:\/\/www.parvilla-invest.fr\/wp-content\/uploads\/2020\/02\/AdobeStock_201606422.jpeg","contentUrl":"https:\/\/www.parvilla-invest.fr\/wp-content\/uploads\/2020\/02\/AdobeStock_201606422.jpeg","width":2560,"height":1440,"caption":"Female and Male Scientists Working on their Computers In Big Modern Laboratory. Various Shelves with Beakers, Chemicals and Different Technical Equipment is Visible."},{"@type":"BreadcrumbList","@id":"https:\/\/www.parvilla-invest.fr\/en\/venture-funds-life-sciences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.parvilla-invest.fr\/en\/"},{"@type":"ListItem","position":2,"name":"Venture Funds \/ Life Sciences"}]},{"@type":"WebSite","@id":"https:\/\/www.parvilla-invest.fr\/fr\/#website","url":"https:\/\/www.parvilla-invest.fr\/fr\/","name":"Parvilla Investissements","description":"Soci\u00e9t\u00e9 d&#039;investissement d\u00e9di\u00e9e au Private Equity","publisher":{"@id":"https:\/\/www.parvilla-invest.fr\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.parvilla-invest.fr\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.parvilla-invest.fr\/fr\/#organization","name":"Parvilla Invest","url":"https:\/\/www.parvilla-invest.fr\/fr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.parvilla-invest.fr\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.parvilla-invest.fr\/wp-content\/uploads\/2020\/01\/logo-1.jpg","contentUrl":"https:\/\/www.parvilla-invest.fr\/wp-content\/uploads\/2020\/01\/logo-1.jpg","width":235,"height":59,"caption":"Parvilla Invest"},"image":{"@id":"https:\/\/www.parvilla-invest.fr\/fr\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.parvilla-invest.fr\/en\/wp-json\/wp\/v2\/pages\/1003","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.parvilla-invest.fr\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.parvilla-invest.fr\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.parvilla-invest.fr\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.parvilla-invest.fr\/en\/wp-json\/wp\/v2\/comments?post=1003"}],"version-history":[{"count":6,"href":"https:\/\/www.parvilla-invest.fr\/en\/wp-json\/wp\/v2\/pages\/1003\/revisions"}],"predecessor-version":[{"id":1391,"href":"https:\/\/www.parvilla-invest.fr\/en\/wp-json\/wp\/v2\/pages\/1003\/revisions\/1391"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.parvilla-invest.fr\/en\/wp-json\/wp\/v2\/media\/1111"}],"wp:attachment":[{"href":"https:\/\/www.parvilla-invest.fr\/en\/wp-json\/wp\/v2\/media?parent=1003"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}